Ironwood Pharmaceuticals | IRWD - Ebitda

Preço das Ações
3.63
Mudança Diária
0.03 0.83%
Mensal
-1.36%
Anual
283.92%
Q2 Previsão
3.53




Ebitda Alterar Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Almirall EUR 114.07M 60.37M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Ardelyx USD 6.02M 447K 2025-12
Astellas Pharma JPY 183.68B 31.98B 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Charles River Laboratories USD 258.06M 24.83M 2025-12
Coherus Biosciences USD -43.33M 4.7M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Incyte USD 414.5M 92.42M 2025-12
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Moderna USD -790M 582M 2025-12
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 38.71M 10.65M 2025-12
PTC Therapeutics USD 20.63M 53.74M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12